• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Dydrogesterone
    3 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Duphaston
    Abbott
    RX
    full basket chart
    Duphaston

    Progestogen. Dydrogesterone 10 mg.
    TABS: 20, 3x14x10 mg. In comb. with cont. estrogen ther: 1 tab dly for 14 consec. days/28 day cycle.
    In comb. with cyclical 
    estrogen ther: 1 tab dly dur. last 12-14 days estrogen ther. If inad. progestational response: 20 mg to be
    given.
    Progeston supplement.
    C/I: Hypersens.

    Femoston 0.5 /2.5 mg, 1/5 mg
    Abbott
    RX
    not in the basket chart
    Multiple ingredients
    Femoston 0.5 /2.5 mg, 1/5 mg

    Progestagens & estrogens. Estradiol 0.5 mg / 1 mg, Dydrogesterone 2.5 mg / 5 mg.
    F.C. TABS.: 28. (1 mg 17β-estradiol / 5 mg dydrogesterone).
    The dosage is 1 tab. per day for a 28 day cycle. The tmt. cycles therefore follow one another without a break.
    For the tmt. of estrogen defic. in postmenopaus. women as an init. and mainten. dose the lowest effective dose should be used and the duration of tmt. period should be kept as short as possible.  In case of no improve. of sympt. within 3 mnths., tmt. should be stopped. See lit.
    HRT for estrogen defic. sympt. in postmenopaus. women at least 12 mnths. since last menses.
    Prevent. of osteoporosis in postmenopaus. women at high risk of future fractures. Should only be used in pts. intoler. of other products, approved for the prevent. of osteoporosis or for whom these products are contra-ind.
    Indic. for women with an intact uterus.
    Experience with tmt. of women >65 yrs. is limited.

    C/I
    :
    Hypersens.
    Presence/suspic. of breast cancer; hist. of breast canc.
    Presence/suspic. of estrogen-sensit. tumours (e.g.endometrial cancer).
    Undiagn. genital bleed.

    Untreated endometr. hyperplasia;

    His. or current venous thromboemb. (e.g. DVT, PE).

    Known thrombophilic condit. (e.g. protein C, protein S or antithrombin defic.)
    Active or recent arterial thromboembolic dis. (e.g. angin. pectoris, MI).
    Acute hep. dis. or hist. of hep. dis. as long as the liver funct. values have not returned to normal.
    Porphyry.

    Femoston 1/10 mg
    Abbott
    RX
    not in the basket chart
    Multiple ingredients
    Femoston 1/10 mg

    Progestagens & estrogens. Estradiol , Dydrogesterone .
    TABS.: 28. (14 white tabs. 1 mg estradiol & 14grey tabs. contain.1 mg estradiol &10 mg dydrogesterone).
    For each cycle of 28 d. for the first 14 d. one white tab. with estradiol is taken once dly. and for the follow. 14 d. one grey tab. with estradiol & dydrogesterone is taken once dly., as indicated on the calendar pack for 28 d.
    After a cycle of 28 d. on the 29th day a new cycle of 28 days begins. The  tmt. cycles therefore follow one another without a break.
    For the tmt. of estrogen defic. in postmenopaus. women as an init. and mainten. dose the lowest effective dose should be used and the duration of tmt. period should be kept as short as possible.  In case of no improve. of sympt. within 3 mnths., tmt. should be stopped.
    In general sequential combined tmt. should be started with Femoston 1/10 mg.
    Depend. on the clinical response the dose can be adjust. accordingly. See lit.
    Hormone replace. ther. for estrogen defic. sympt. in postmenopaus. women at least 6 mnths. since last menses.
    Prevent. of osteoporosis in postmenopaus. women at high risk of future fractures. Should only be used in pts. intoler. of other products, approved for the prevent. of osteoporosis or for whom these products are contra-ind.
    Femoston is indic. for women with an intact uterus.
    Experience with tmt. of women >65 yrs. is limited.

    C/I
    :
    Hypersens.
    Presence/ suspic.of breast cancer; hist. of breast canc.
    Presence / suspic. of estrogen-sensit. tumours (e.g.endometrial cancer).
    Vag. bleed. of which the cause has not been determined;
    Untreated endometr. hyperplasia;
    History of active venous thromboembolism  (DVT, PE).
    Presence of a thrombophilic condit. (e.g. protein C, protein S or antithrombin defic.
    Active or recent arterial thromboembolic dis.(angin.  pectoris, MI).
    Acute hep. dis.  or history of hep. dis. as long as the liver funct.  values have not returned to normal.
    Porphyry.

    CLOSE